Leading telemedicine service platform KonsultaMD and leading health and beauty store chain Watsons Philippines have partnered to give FREE healthcare to Filipinos nationwide.
Aside from being a one-stop-shop for personal and medical needs, Watsons Philippines now provides FREE 24/7 unlimited doctor consultations to its customers via KonsultaMD for a minimum purchase of P500.
For KonsultaMD members, Watsons offers FREE delivery for at least P1,000 worth of purchase from their official website www.watsons.com.ph or via the Watsons mobile app, which can be downloaded on Google Play, AppStore, and AppGallery.
“The partnership between KonsultaMD and Watsons provides customers a very convenient way to access doctor consultation and pharmacy service online. We look forward to a seamless customer experience between our digital platforms.” said Joseph Soliman, Health Business Development Controller of Watsons.
The free KonsultaMD health plan can be enjoyed by up to five family members for one month. They can talk to a licensed general physician anytime via voice, or video call, with no appointment needed.
Aside from primary medical advice, KonsultaMD members can receive general health information and interpretation of laboratory results and diagnostic examinations.
Moreover, they can have access to important medical documents such as e-prescriptions, e-laboratory requests, and e-medical certificates at the doctor’s discretion.
“We are excited over this partnership with Watsons since we want healthcare to be accessible to as many Filipinos as possible. Now, we can provide health coverage to many families by just shopping at Watsons,” said Cholo Tagaysay, KonsultaMD Chief Executive Officer.
KonsultaMD is working to make healthcare available to everyone, everywhere all the time by collaborating with retailers such as drugstores, convenience stores, and other establishments nationwide.
Download the KonsultaMD app on Google Play, AppStore, and AppGallery. Know more about the partnership by visiting https://use.konsulta.md/watsons.
No comments:
Post a Comment